Mixer parts

The British singer took home the award for “Best Album” for 21 and that of “Female Artist” on Tuesday evening in London.

Adele never stops to receive awards. Named in three categories, the British singer is distributed on Tuesday night, with two Brit Awards including “Best Album” for 21 and that of “Female Artist” of the year. Only the Award for “Song of the Year” for Someone Like You, eluded him. He was assigned to the English group One Direction, for her single What Makes you Beautiful.

The interpreter of Set Fire to the Rain said she was very happy to receive so many awards. “Nothing makes me prouder than to go home with six Grammys and now take the prize for best album at the Brit Awards. I am so proud to be British and to wear the flag. ”

The singer has once again demonstrated, during his performance, his voice had lost none of its charm. Last year, she had interpreted Someone Like You for the first time and had upset the public. Tuesday, she delivered an impressive vocal performance on the title favorite Rolling in the Deep. Simply accompanied by a small orchestra, she was greeted by a standing ovation.

Initially invited to the Oscars to be held this Sunday, Sacha Baron Cohen has become persona non grata. The Academy does not want to see land made ​​up as dictator, the character he plays in his latest film.

Two choices are offered to him donning a tuxedo all there is more conventional and attend the 84th Academy Awards, or dress up as dictator and watch high mass Hollywood movies on television. According Deadline.com, the American Academy of Arts and Sciences Film withdrew to Sacha Baron Cohen’s invitation to the Oscars.

While it is part of the team of Hugo Cabret, Martin Scorsese’s film, which topped the nominations, the British actor might miss the party. The reason? As he did in 2009 MTV Movie Awards when he came in Brüno, the gay Austrian journalist he embodied in one of his movies, Sacha Baron Cohen had come on Sunday at the Kodak Theather in Los Angeles disguised as a dictator, character in his next feature film (the Dictator). But now, we do not mess with the Oscars. The Academy has therefore meant that it would be welcome if it renounced its happening. After all, it can comply with this injunction: it is already providing a good shot of his promotional film with the ultimatum that has been launched.

The project was tempting but Ryan Philippe decides to leave the project Golden Boy series for CBS, where he was cast as a cop.

Ryan Philippe, rare on the big screen despite its recent performance in The Lincoln Lawyer, could rebound in Golden Boy. This mystery series set on CBS put headlining the Hollywood bad-boy. He was to play Clark, a young cop dazzling career. Unfortunately, the actor has decided to abandon, announces Deadline.

Fear of commitment

Less than two weeks after the signing of the project, Ryan Philippe retracts. A tacit agreement has been signed between the actor and the show’s producers felt that Ryan Phillippe was not prepared to engage in a potentially-long project. While he is currently shooting in season 5 of Damages, the actor realized the importance of working time and production of a television series.

The disappointment is huge but we can always find him in the final season of Damages, which will begin in July 2012 in the United States. And soon in the Chronicle thriller starring Milla Jovovich and Justin Long, who deals with drug trafficking.

By cons, the two actors Chi McBride, Pushing Daisies, and Kevin Alejandro, Southland, True Blood-are always present in the casting of the series Golden Boy. The question is which actor has the caliber to replace Ryan Philippe. The paris are open.

U.S.: Home sales in a year and half maximum
Sales of existing homes in the U.S. rose in January to its highest level in a year and a half, while the supply of homes on the market reached a low in nearly seven years, which points to a nascent recovery in the market housing.

The National Association of Realtors (NAR for its acronym in English) said Wednesday that sales of existing homes rose 4.3 percent to an annual rate of 4.57 million units last month, reaching its best level since May 2010.

“Overall, this is not a bad number. It reflects better labor market, but the improvement will be irregular,” said Yelena Shulyatyeva, U.S. economist at BNP Paribas in New York.

However, the tenor of the report was tempered by the revision of the December figure to show that it sold 4.38 million units, instead of the 4.61 million originally estimated.

That followed an annual review of seasonal factors for the series to following years. Sales in December fell 0.5 percent from November, instead of the 5 percent increase reported last month.

There were no revisions to monthly prices and inventory figures. Economists polled by Reuters had expected sales of 4.65 million in January.

The report adds to tentative signs of improvement in the housing market. The inventory of unsold homes on the market is shrinking.

Last month, there were 2.31 million unsold homes on the market, the lowest since March 2005. This represents a supply of 6.1 months to January sales pace, the lowest level since April 2006 and falling to 6.4 months in December.

An offer of 6 months is generally considered ideal. However, the drop in inventories might have been encouraged by a drop in home prices.

The average price of a used home fell 2 percent to $ 154,700 in January from the same month last year.

The Federal Reserve has suggested a number of ways that government authorities could take to help the beaten housing market, including giving a greater role in the refinancing of loans to mortgage giants Fannie Mae of Freddie Mac and

Sales of confiscated properties, foreclosures and short sales, which traditionally occur with deep discounts, accounted for 35 percent of overall sales last month, compared with 32 percent in December. A third of the sales contracts were canceled, the NAR said.

The U.S. Food and Drug Administration (FDA, its acronym in English) announced Tuesday it will take a number of steps to enhance and ensure the delivery of cancer drugs most needed, in response to an executive order of President Barack Obama to avoid shortages of these drugs.

This is because of the severe shortage of some cancer drugs as therapy for ovarian cancer liposomal doxorubicin hydrochloride, marketed as ‘Doxil’ by Johnson & Johnson, or the rapid decline in supplies of methotrexate.

“The potential shortage of medicines in the future offers a frightening prospect for patients,” said Commissioner has recognized this entity, Margaret A. Hamburg, which is why President Obama has urged the FDA to “prevent these gaps is a priority.”

To this end, the agency has decided to temporarily import a replacement for ‘Doxil’, the ‘LipoDox’, in order to end this shortage and fully meet patient needs in the coming weeks.

This drug is also indicated for use in Kaposi’s sarcoma associated with AIDS and multiple myeloma, although in both cases, the FDA provides that the entry of ‘LipoDox’ allow full satisfaction.